The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Wild-Type and Mutant Huntingtins Function in Vesicle Trafficking in the Secretory and Endocytic Pathways
Abstract
Huntingtin is a cytoplasmic protein that is found in neurons and somatic cells. In patients with Huntington's disease (HD), the NH2-terminal region of huntingtin has an expanded polyglutamine tract. An abnormal protein interaction by mutant huntingtin has been proposed as a mechanism for HD pathogenesis. Huntingtin associates with vesicle membranes and interacts with proteins involved in vesicle trafficking. It is unclear where along vesicle transport pathways wild-type and mutant huntingtins are found and whether polyglutamine expansion affects this localization. To distinguish wild-type and mutant huntingtin, fibroblasts from normals and HD patients with two mutant alleles (homozygotes) were examined. Immunofluorescence confocal microscopy showed that mutant huntingtin localized with clathrin in membranes of the trans Golgi network and in clathrin-coated and noncoated endosomal vesicles in the cytoplasm and along plasma membranes. Separation of organelles in Nycodenz gradients showed that in normal and HD homozygote patient cells, huntingtin was present in membrane fractions enriched in clathrin. Similar results were obtained in fibroblasts from heterozyote juvenile HD patients who had a highly expanded polyglutamine tract in the HD allele. Western blot analysis of membrane fractions from rat brain showed that wild-type huntingtin was present in fractions that contained purified clathrin-coated membranes or a mixture of clathrin-coated and noncoated membranes. Electron micr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A potential cargo for HIP1 is huntingtin.
“A potential cargo for HIP1 is huntingtin, which interacts with the N-terminal segment of HIP1 (Wanker et al., 1997) and has been localized to clathrin-coated structures and endosomes (Velier et al., 1998).”
From Disabled‐2 exhibits the properties of a cargo‐selective endocytic clathrin adaptor (2002) · cites this paper as Velier et al., 1998
Huntingtin has been localized to clathrin-coated structures and endosomes.
“A potential cargo for HIP1 is huntingtin, which interacts with the N-terminal segment of HIP1 (Wanker et al., 1997) and has been localized to clathrin-coated structures and endosomes (Velier et al., 1998).”
From Disabled‐2 exhibits the properties of a cargo‐selective endocytic clathrin adaptor (2002) · cites this paper as Velier et al., 1998
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Flagged first, then by citations
Research works printed but not linked: 38
- Aronin, 1995, CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain, Neuron, 15, 1193, 10.1016/0896-6273(95)90106-X · DOI
- Trottier, 1995, Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form, Nature Genet., 10, 104, 10.1038/ng0595-104 · DOI
- Vonsattel, 1985, Neuropathological classification of Huntington's disease, J. Neuropathol. Exp. Neurol., 44, 559, 10.1097/00005072-198511000-00003 · DOI · Paper page
- DiFiglia, 1997, Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, 277, 1990, 10.1126/science.277.5334.1990 · DOI · Paper page
- Aronin, 1995, Clues to huntingtin's normal and abnormal function, J. NIH Res., 7, 55
- DiFiglia, 1995, Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons, Neuron, 14, 1075, 10.1016/0896-6273(95)90346-1 · DOI · Paper page
- Gutekunst, 1995, Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies, Proc. Natl. Acad. Sci. USA, 92, 8710, 10.1073/pnas.92.19.8710 · DOI
- Sharp, 1995, Widespread expression of Huntington's disease gene (IT15) protein product, Neuron, 14, 1065, 10.1016/0896-6273(95)90345-3 · DOI
- Kalchman, 1997, HIP1, a human homologue ofS. cerevisiae, Nature Genet., 16, 44, 10.1038/ng0597-44 · DOI
- Wanker, 1997, HIP-1: A huntingtin interacting protein isolated by the yeast two-hybrid system, Human Mol. Genet., 6, 487, 10.1093/hmg/6.3.487 · DOI · Paper page
- Li, 1995, A huntingtin-associated protein enriched in brain with implications for HD pathology, Nature, 378, 398, 10.1038/378398a0 · DOI
- Li, 1996, Huntingtin-associated protein (HAP1): Discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase, Proc. Natl. Acad. Sci. USA, 93, 4839, 10.1073/pnas.93.10.4839 · DOI
- Bhide, 1996, Expression of normal and mutant huntingtin in the developing brain, J. Neurosci., 16, 5523, 10.1523/JNEUROSCI.16-17-05523.1996 · DOI
- Hammond, 1994, Quality control in the secretory pathway: Retention of misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus, J. Cell. Biol., 126, 41, 10.1083/jcb.126.1.41 · DOI · Paper page
- Pearse, B. M. F. 1989, Methods in Cell Biology, 31, 229, 243, Academic Press, San Diego, CA · DOI
- Pley, 1993, Clathrin: Its role in receptor-mediated vesicular transport and specialized functions in neurons, Crit. Rev. Biochem. Mol. Biol., 28, 431, 10.3109/10409239309078441 · DOI
- Hopkins, 1983, Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells, J. Cell. Biol., 97, 508, 10.1083/jcb.97.2.508 · DOI
- Stoorvogel, 1996, A novel class of clathrin-coated vesicles budding from endosomes, J. Cell. Biol., 132, 21, 10.1083/jcb.132.1.21 · DOI
- Pearse, 1990, Clathrin, adaptors and sorting, Annu. Rev. Cell Biol., 6, 151, 10.1146/annurev.cb.06.110190.001055 · DOI
- Raths, 1993, end3end4:Saccaromydes cervisiae, J. Cell. Biol., 120, 55, 10.1083/jcb.120.1.55 · DOI
- Wesp, 1997, End4p/Sla2p interacts with actin-associated proteins for endocytosis inSaccharomyces cerevisiae, Mol. Biol. Cell, 8, 2291, 10.1091/mbc.8.11.2291 · DOI
- Vieira, 1996, Control of EGF receptor signaling by clathrin-mediated endocytosis, Science, 274, 2086, 10.1126/science.274.5295.2086 · DOI · Paper page
- Liu, 1997, Sh3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes, J. Biol. Chem., 272, 8121, 10.1074/jbc.272.13.8121 · DOI
- Vaughan, 1995, Cytoplasmic dynein binds dynactin through a direct interaction between the intermediate chains and p150Glued, J. Cell. Biol., 131, 1507, 10.1083/jcb.131.6.1507 · DOI
- DeCamilli, 1996, Molecular mechanisms in synaptic vesicle endocytosis and recycling, Neuron, 16, 481, 10.1016/S0896-6273(00)80068-9 · DOI
- Engelender, 1997, Huntingtin-associated protein 1 (HAP 1) interacts with the p150glued, Human Mol. Genet., 6, 2205, 10.1093/hmg/6.13.2205 · DOI
- Block-Galarza, 1997, Fast transport and retrograde movement of huntingtin and HAP-1 in axons, Neuroreport, 8, 2247, 10.1097/00001756-199707070-00031 · DOI
- von Zastrow, 1992, Ligand-induced internalization and recycling of human β-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors, J. Biol. Chem., 267, 3530, 10.1016/S0021-9258(19)50762-1 · DOI
- Ferguson, 1990, Basic fibroblast growth factor: Receptor-mediated internalization, metabolism, and anterograde axonal transport in retinal ganglion cells, J. Neurosci., 10, 2176, 10.1523/JNEUROSCI.10-07-02176.1990 · DOI
- Mantyh, 1995, Rapid endocytosis of a G-protein-coupled receptor: Substance P evoked internalization of its receptor in the rat striatumin vivo, Proc. Natl. Acad. Sci. USA, 92, 2622, 10.1073/pnas.92.7.2622 · DOI
- Faure, 1995, Somatodendritic internalization and perinuclear targeting of neurotensin in the mammalian brain, J. Neurosci., 15, 4140, 10.1523/JNEUROSCI.15-06-04140.1995 · DOI
- Grady, 1995, Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor, Mol. Brain Res., 6, 509
- Reiner, 1988, Differential loss of striatal projection neurons in Huntington disease, Proc. Natl. Acad. Sci. USA, 85, 5733, 10.1073/pnas.85.15.5733 · DOI · Paper page
- Augood, 1996, Reduction in enkephalin and substance P mRNA in the striatum of early grade Huntington's disease: A detailed cellularin situ, Neuroscience, 72, 1023, 10.1016/0306-4522(95)00595-1 · DOI
- Sapp, 1995, Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis, Neuroscience, 64, 397, 10.1016/0306-4522(94)00427-7 · DOI
- Richfield, 1995, Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients, Ann. Neurol., 37, 335, 10.1002/ana.410370309 · DOI
- Weeks, 1996, Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease, Ann. Neurol., 40, 49, 10.1002/ana.410400110 · DOI · Paper page
- DiFiglia, 1997, Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, 277, 1990, 10.1126/science.277.5334.1990 · DOI · Paper page
Cited by
Sorted by citations
Disabled‐2 exhibits the properties of a cargo‐selective endocytic clathrin adaptor
Mishra, S. K., Keyel, P. A., Hawryluk, M. J., Agostinelli, N. R., Watkins, S. C., & Traub, L. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf487 · Cited by 302
Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles
Hilditch-Maguire, P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2789 · Cited by 226
Synaptic dysfunction in Huntington's disease: a new perspective
Smith, R., Brundin, P., & Li, J.-Y. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5084-5 · Cited by 166
The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders
Vidoni, C., Follo, C., Savino, M., Melone, M. A. B., & Isidoro, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21394 · Cited by 164
Huntingtin-deficient zebrafish exhibit defects in iron utilization and development
Lumsden, A. L., Henshall, T. L., Dayan, S., Lardelli, M. T., & Richards, R. I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm138 · Cited by 156
Luthi-Carter, R., Apostol, B. L., Dunah, A. W., DeJohn, M. M., Farrell, L. A., Bates, G. P., Young, A. B., Standaert, D. G., Thompson, L. M., & Cha, J.-H. J. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.024 · Cited by 104
Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease
Caron, N. S., Banos, R., Yanick, C., Aly, A. E., Byrne, L. M., Smith, E. D., Xie, Y., Smith, S. E. P., Potluri, N., Findlay Black, H., et al. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.1865-20.2020 · Cited by 66
Axonopathy in Huntington's disease
Li, J.-Y., & Conforti, L. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.010 · Cited by 55
Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder
Trujillo-Del Río, C., Tortajada-Pérez, J., Gómez-Escribano, A. P., Casterá, F., Peiró, C., Millán, J. M., Herrero, M. J., & Vázquez-Manrique, R. P. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111670 · Cited by 19
Metadata
- Authors
- Velier, J., Kim, M., Schwarz, C., Kim, T. W., Sapp, E., Chase, K., Aronin, N., & DiFiglia, M.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 1998-07
- Volume
- 152
- Issue
- 1
- Pages
- 34-40
- ISSN
- 0014-4886
- Cited by
- 258
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review